177 related articles for article (PubMed ID: 25651777)
21. XPC gene mutations in families with xeroderma pigmentosum from Pakistan; prevalent founder effect.
Ijaz A; Basit S; Gul A; Batool L; Hussain A; Afzal S; Ramzan K; Ahmad J; Wali A
Congenit Anom (Kyoto); 2019 Jan; 59(1):18-21. PubMed ID: 29569758
[TBL] [Abstract][Full Text] [Related]
22. Nonselective TRPC channel inhibition and suppression of aminoglycoside-induced premature termination codon readthrough by the small molecule AC1903.
Baradaran-Heravi A; Bauer CC; Pickles IB; Hosseini-Farahabadi S; Balgi AD; Choi K; Linley DM; Beech DJ; Roberge M; Bon RS
J Biol Chem; 2022 Feb; 298(2):101546. PubMed ID: 34999117
[TBL] [Abstract][Full Text] [Related]
23. Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAs in a mammalian translation system.
Keeling KM; Bedwell DM
J Mol Med (Berl); 2002 Jun; 80(6):367-76. PubMed ID: 12072912
[TBL] [Abstract][Full Text] [Related]
24. Effect of small molecule eRF3 degraders on premature termination codon readthrough.
Baradaran-Heravi A; Balgi AD; Hosseini-Farahabadi S; Choi K; Has C; Roberge M
Nucleic Acids Res; 2021 Apr; 49(7):3692-3708. PubMed ID: 33764477
[TBL] [Abstract][Full Text] [Related]
25. Gentamicin B1 is a minor gentamicin component with major nonsense mutation suppression activity.
Baradaran-Heravi A; Niesser J; Balgi AD; Choi K; Zimmerman C; South AP; Anderson HJ; Strynadka NC; Bally MB; Roberge M
Proc Natl Acad Sci U S A; 2017 Mar; 114(13):3479-3484. PubMed ID: 28289221
[TBL] [Abstract][Full Text] [Related]
26. Genetic correction of DNA repair-deficient/cancer-prone xeroderma pigmentosum group C keratinocytes.
Arnaudeau-Bégard C; Brellier F; Chevallier-Lagente O; Hoeijmakers J; Bernerd F; Sarasin A; Magnaldo T
Hum Gene Ther; 2003 Jul; 14(10):983-96. PubMed ID: 12869216
[TBL] [Abstract][Full Text] [Related]
27. A new XPC gene splicing mutation has lead to the highest worldwide prevalence of xeroderma pigmentosum in black Mahori patients.
Cartault F; Nava C; Malbrunot AC; Munier P; Hebert JC; N'guyen P; Djeridi N; Pariaud P; Pariaud J; Dupuy A; Austerlitz F; Sarasin A
DNA Repair (Amst); 2011 Jun; 10(6):577-85. PubMed ID: 21482201
[TBL] [Abstract][Full Text] [Related]
28. A novel XPC pathogenic variant detected in archival material from a patient diagnosed with Xeroderma Pigmentosum: a case report and review of the genetic variants reported in XPC.
Rivera-Begeman A; McDaniel LD; Schultz RA; Friedberg EC
DNA Repair (Amst); 2007 Jan; 6(1):100-14. PubMed ID: 17079196
[TBL] [Abstract][Full Text] [Related]
29. [Novel mutations of XPC gene detected in a family affected with xeroderma pigmentosum group C].
Wang L; Huang S; Li J; Zou Y; Xu P; Gao M; Kang R; Xie H; Wei X; Niu Y; Liu X; Gao Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Aug; 35(4):540-543. PubMed ID: 30098252
[TBL] [Abstract][Full Text] [Related]
30. Complementation of the DNA repair deficiency in human xeroderma pigmentosum group a and C cells by recombinant adenovirus-mediated gene transfer.
Muotri AR; Marchetto MC; Zerbini LF; Libermann TA; Ventura AM; Sarasin A; Menck CF
Hum Gene Ther; 2002 Oct; 13(15):1833-44. PubMed ID: 12396616
[TBL] [Abstract][Full Text] [Related]
31. Two essential splice lariat branchpoint sequences in one intron in a xeroderma pigmentosum DNA repair gene: mutations result in reduced XPC mRNA levels that correlate with cancer risk.
Khan SG; Metin A; Gozukara E; Inui H; Shahlavi T; Muniz-Medina V; Baker CC; Ueda T; Aiken JR; Schneider TD; Kraemer KH
Hum Mol Genet; 2004 Feb; 13(3):343-52. PubMed ID: 14662655
[TBL] [Abstract][Full Text] [Related]
32. Aminoglycoside-induced suppression of CYP2C19*3 premature stop codon.
Fuchshuber-Moraes M; Carvalho RS; Rimmbach C; Rosskopf D; Carvalho MA; Suarez-Kurtz G
Pharmacogenet Genomics; 2011 Nov; 21(11):694-700. PubMed ID: 21934639
[TBL] [Abstract][Full Text] [Related]
33. Rescue of non-sense mutated p53 tumor suppressor gene by aminoglycosides.
Floquet C; Deforges J; Rousset JP; Bidou L
Nucleic Acids Res; 2011 Apr; 39(8):3350-62. PubMed ID: 21149266
[TBL] [Abstract][Full Text] [Related]
34. A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa.
Soufir N; Ged C; Bourillon A; Austerlitz F; Chemin C; Stary A; Armier J; Pham D; Khadir K; Roume J; Hadj-Rabia S; Bouadjar B; Taieb A; de Verneuil H; Benchiki H; Grandchamp B; Sarasin A
J Invest Dermatol; 2010 Jun; 130(6):1537-42. PubMed ID: 20054342
[TBL] [Abstract][Full Text] [Related]
35. Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): xeroderma pigmentosum without and with Cockayne syndrome.
Oh KS; Khan SG; Jaspers NG; Raams A; Ueda T; Lehmann A; Friedmann PS; Emmert S; Gratchev A; Lachlan K; Lucassan A; Baker CC; Kraemer KH
Hum Mutat; 2006 Nov; 27(11):1092-103. PubMed ID: 16947863
[TBL] [Abstract][Full Text] [Related]
36. Xeroderma pigmentosum group C splice mutation associated with autism and hypoglycinemia.
Khan SG; Levy HL; Legerski R; Quackenbush E; Reardon JT; Emmert S; Sancar A; Li L; Schneider TD; Cleaver JE; Kraemer KH
J Invest Dermatol; 1998 Nov; 111(5):791-6. PubMed ID: 9804340
[TBL] [Abstract][Full Text] [Related]
37. Effect of Readthrough Treatment in Fibroblasts of Patients Affected by Lysosomal Diseases Caused by Premature Termination Codons.
Matalonga L; Arias Á; Tort F; Ferrer-Cortés X; Garcia-Villoria J; Coll MJ; Gort L; Ribes A
Neurotherapeutics; 2015 Oct; 12(4):874-86. PubMed ID: 26169295
[TBL] [Abstract][Full Text] [Related]
38. Sequence specificity of aminoglycoside-induced stop condon readthrough: potential implications for treatment of Duchenne muscular dystrophy.
Howard MT; Shirts BH; Petros LM; Flanigan KM; Gesteland RF; Atkins JF
Ann Neurol; 2000 Aug; 48(2):164-9. PubMed ID: 10939566
[TBL] [Abstract][Full Text] [Related]
39. [Therapeutic readthrough strategy for suppression of nonsense mutations in duchenne muscular dystrophy].
Shiozuka M; Matsuda R
Brain Nerve; 2011 Nov; 63(11):1253-60. PubMed ID: 22068478
[TBL] [Abstract][Full Text] [Related]
40. Aminoglycosides and other factors promoting stop codon readthrough in human cells.
Diop D; Chauvin C; Jean-Jean O
C R Biol; 2007 Jan; 330(1):71-9. PubMed ID: 17241950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
